Top compounds associated with response to USP17L29


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.03
mRNA purmorphamine CTRPv2 pan-cancer AAC -0.08 0.03
mRNA SCH-79797 CTRPv2 pan-cancer AAC 0.074 0.03
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC 0.076 0.03
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.062 0.03
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.072 0.04
mRNA tivozanib CTRPv2 pan-cancer AAC 0.075 0.04
mRNA Bleomycin CTRPv2 pan-cancer AAC 0.075 0.04
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.04
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.04
Download CSV